Author:
HASANAH USWATUL,WAHYUNI LIZA,ZAINI ERIZAL
Abstract
Objective: This study aims to increase the solubility and dissolution rate of fenofibric acid by forming a micronized eutectic mixture of fenofibric acid-saccharin with spray drying technique.
Methods: Suspension of the eutectic mixture was prepared in ethanol: distilled water (3:1) followed by a spray drying method to obtain the microparticles. Microparticles characterization was performed by particle size analysis (PSA), powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), FT-IR spectroscopy, and scanning electron microscopy (SEM). Solubility test was carried out in CO2-free distilled water, meanwhile the dissolution rate study was conducted in phosphate buffer solution at pH 6.8.
Results: The results showed the mean of the samples’ particle size was 72.29±7.33 µm. Compared to the intact fenofibric acid, the micronized eutectic mixture sample has a decreased melting point, fusion enthalpy, and crystallinity without any wavenumber shifted in the FT-IR spectra. The solubility of micronized eutectic mixture was 2.2 times higher than intact fenofibric acid, while the amount of micronized eutectic mixture dissolved at 60 min was 11.7 times higher.
Conclusion: It can be concluded that the spray-dried micronized eutectic mixture of fenofibric acid-saccharin was having the ability to enhance the dissolution of fenofibric acid.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference20 articles.
1. Sun T, Hall ML, Isbester PK. White heat BR. Fenofibric acid polymorph; methods of making; and methods of use thereof. United states application publication. Vol. 56(4); 2009.
2. Shukla AK, Bishnoi RS, Dev SK, Khumar M, Fenin V. Biopharmaceutical classification system: tool-based prediction for drug dosage formulation. Adv Pharm J. 2017;2(6):204-10.
3. Windriyati YN, Sumirtapura YC, Pamudji JS. Comparative in vitro and in vivo evaluation of fenofibric acid as an antihyperlipidemic drug. Turk J Pharm Sci. 2020 Apr 1;17(2):203-10. doi: 10.4274/tjps.galenos.2019.27147, PMID 32454781.
4. Hens B, Brouwers J, Corsetti M, Augustijns P. Gastrointestinal behavior of nano- and microsized fenofibrate: in vivo evaluation in man and in vitro simulation by assessment of the permeation potential. Eur J Pharm Sci. 2015;77:40-7. doi: 10.1016/j.ejps.2015.05.023.
5. Anggraini D, Umar S, Arifin H, Zaini E. Dissolution rate enhancement and physicochemical characterization of a fenofibric acid–nicotinamide eutectic mixture. Trop J Nat Prod Res (TJNPR). 2021 Sep 1;5(9):1614-8. doi: 10.26538/tjnpr/v5i9.